Ankerstar Wealth’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$294 Hold
16
– – ﹤0.01% 848
2026
Q2
$233 Sell
16
-20
-56% -$193 ﹤0.01% 864
2026
Q1
$267 Buy
36
+18
+100% +$189 ﹤0.01% 792
2025
Q4
$212 Buy
+18
New +$194 ﹤0.01% 878

Other funds holding NEO

Ankerstar Wealth's NEO Position: Q3 2026 in Review

Ankerstar Wealth held its NeoGenomics (NEO) position steady in Q3 2026 at 16 shares worth $294. The position accounts for ﹤0.01% of the portfolio, ranked #848.

Ankerstar Wealth first reported a position in NEO in Q4 2025 and has held it in 4 quarters since. 297 funds tracked by Wall St. Rank hold NEO as of Q3 2026.

  • Ankerstar Wealth held 16 shares of NeoGenomics worth $294 as of Q3 2026.
  • Ankerstar Wealth left its NeoGenomics share count unchanged in Q3 2026.
  • NeoGenomics made up ﹤0.01% of Ankerstar Wealth's portfolio in Q3 2026, its #848 holding.
  • Ankerstar Wealth first reported a position in NeoGenomics in Q4 2025 and has held it in 4 quarters since.
  • 297 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2026.

Based on Ankerstar Wealth's 13F filing for Q3 2026, filed 13 Nov 2026.